General Information of the Compound
Compound ID |
CP0044037
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N,N-dimethyl-3-[2-(trifluoromethyl)-10-phenothiazinyl]-1-propanamine;hydrochloride
Show/Hide
|
||||||||||||||||||
Synonyms |
Adazine
Fluopromazine
Fluopromazine monohydrochloride
Fluorofen
Neoprin
Nivoman
Psyquil
Siquil
Trifluopromazine
Trifluopromazine hydrochloride
Triflupromazina
Triflupromazina [INN-Spanish]
Triflupromazine
Triflupromazine (USP/INN)
Triflupromazine [INN]
Triflupromazinum [INN-Latin]
Triflupromazinum;Vesprin
Vesprin (TN)
Vetame
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H19F3N2S
|
||||||||||||||||||
Molecular Weight |
352.425
|
||||||||||||||||||
Canonical SMILES |
CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3
Show/Hide
|
||||||||||||||||||
InChIKey |
XSCGXQMFQXDFCW-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
17146-88-2
146-54-3
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Clinical Information about the Compound
Drug 1 ( Triflupromazine )
Drug Name | Triflupromazine | ||
---|---|---|---|
Company | Bristol-Myers Squibb | ||
Indication | |||
Target(s) |